Log in or Sign up for Free to view tailored content for your specialty!
Viral Hepatitis News
Lower diagnostic costs needed for HBV peripartum antiviral prophylaxis to be effective
The addition of peripartum antiviral prophylaxis to reduce neonatal hepatitis B virus infection could have “substantial extra health benefits,” although decreased diagnostic costs are needed to make this strategy cost-effective.
Healio seeks nominees for Disruptive Innovators Awards in gastroenterology
Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.
Log in or Sign up for Free to view tailored content for your specialty!
Transplant medicine contends with organ shortage and pandemic-related disruptions
Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.
Biden: ‘Every American can do their part’ to eliminate viral hepatitis epidemic in US
May is Hepatitis Awareness Month, an annual campaign to raise awareness for viral hepatitis and its impact in the U.S. — and a month-long opening to address the importance of vaccination and testing for viral hepatitis with your patients.
Adenovirus re-emerges as likely culprit in 2022 outbreak of acute hepatitis in children
A 2022 outbreak of unexplained acute severe hepatitis in children has been linked to a strain of adeno-associated virus 2, supporting the theory that disease pathogenesis results from viral coinfection, according to data reported in Nature.
90-day fills for chronic hepatitis B treatments increased patient adherence
Being prescribed a 90-day or a “mixed duration” supply of entecavir or tenofovir disoproxil fumarate was associated with higher fill rates among commercially insured patients with chronic hepatitis B, researchers found.
CDC recommends hepatitis B testing for all adults
The CDC has updated its guidance for hepatitis B testing for the first time since 2008 and now recommends that all adults in the U.S. be tested for HBV at least once in their lifetime.
HIV, HBV, HCV testing up among Medicaid enrollees, although missed opportunities remain
Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.
Current drug use does not hinder treatment of hepatitis C virus
WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.
Mystery hepatitis culprit still unidentified: Timeline of a global outbreak in children
Since April 2022, more than 1,300 children in 35 countries have developed acute severe hepatitis of unknown etiology, with the United States and the United Kingdom accounting for 65% of global cases, according to recent WHO data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read